Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
03:04:27 EDT Wed 25 Jun 2025
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

T:MDNA - MEDICENNA THERAPEUTICS CORP. J - https://www.medicenna.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
MDNA - T  16.50.85·0.910.50.85-0.02-2.344.437480.87  0.88  0.852.625  0.85Jun 24May 0215 min RT 2¢
TSX - T16.50.85·0.910.50.85-0.02-2.331.527170.87  0.88  0.852.625  0.85Jun 2415 min
NEO ATS - U 0.86-0.01-1.11.0110.86  0.86  0.86Jun 2415 min
Alpha - A 0.88+0.011.16.0550.88  0.88  0.88Jun 2415 min
Omega - O 0.86-0.01-1.11.5120.86  0.86  0.86Jun 2415 min
Chi-X - X 0.86-0.01-1.10.5010.86  0.86  0.86Jun 2415 min
CX2 - H 0.88+0.011.11.0120.86  0.88  0.86Jun 2415 min
CXD - D 0.871.017    Jun 1615 min
TriAct - M 0.871.0112    Sep 11-2015 min
Lynx - Y 0.85-0.02-2.31.0110.85  0.85  0.85Jun 2415 min

Recent Trades - Last 10 of 48
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:59:09T0.85-0.026,500124 Questrade7 TD SecK
15:45:59A0.880.015007 TD Sec79 CIBCK
15:45:59A0.880.013,5007 TD Sec79 CIBCK
15:45:59H0.880.015007 TD Sec2 RBCK
15:45:59T0.880.015007 TD Sec7 TD SecK
15:45:59T0.880.015007 TD Sec1 AnonymousK
15:45:59T0.880.015007 TD Sec7 TD SecK
15:26:24D0.880.012007 TD Sec7 TD SecE
15:26:24A0.880.011,0007 TD Sec79 CIBCK
15:25:11A0.880.015007 TD Sec79 CIBCK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-05-02 14:42C:MDNA1.22SEDAR Preliminary Short Form ProspectusSEDAR Preliminary Short Form Prospectus
2025-05-02 10:00C:MDNASEDAR Final Short Form ProspectusSEDAR Final Short Form Prospectus
2025-04-30 18:09C:MDNA1.16News ReleaseMedicenna presents preclinical MDNA113 data at meeting
2025-04-28 19:36C:MDNA1.10News ReleaseMedicenna's MDNA11 showing acceptable safety profile
2025-04-22 07:00C:MDNA1.06News ReleaseMedicenna to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference
2025-04-01 07:00C:MDNA0.98News ReleaseMedicenna to Present at Jones Healthcare and Technology Innovation Conference
2025-03-26 15:24C:MDNA0.99News ReleaseMedicenna to present MDNA11 update at AACR
2025-02-25 15:46C:MDNA1.13News ReleaseMedicenna talks MDNA11 Ability-1 study data
2025-02-13 10:28C:MDNA1.27News ReleaseMedicenna Reports Third Quarter Fiscal 2025 Financial and Operational Results and Provides Anticipated Milestones
2025-02-12 21:03C:MDNA1.27SEDAR Interim MD & ASEDAR Interim MD & A
2025-02-05 07:00C:MDNA1.26News ReleaseMedicenna Therapeutics to Participate in Two Healthcare Investor Conferences in February 2025
2024-12-13 08:30C:MDNA1.81News ReleaseMedicenna Presents Preclinical Data on MDNA11 as First Step to Shrink Tumors Before Surgery and Prevent Metastasis at the 2024 San Antonio Breast Cancer Symposium (SABCS)
2024-12-05 07:35C:MDNA1.66News ReleaseMedicenna Provides Clinical Update and Announces First Complete Responder in MDNA11 and KEYTRUDA(TM) (pembrolizumab) Combination Dose Escalation Arm of the ABILITY-1 Study
2024-11-27 07:00C:MDNA1.77News ReleaseUpdated MDNA11 Monotherapy and Combination Clinical Data from the Ongoing Phase 1/2 ABILITY-1 Study to be Presented at the 2024 Immunotherapy Bridge Conference
2024-11-25 07:30C:MDNA1.57News ReleaseMedicenna Presents Preclinical Data on MDNA11 and Bizaxofusp at the 2024 Annual Meeting of the Society for Neuro-Oncology (SNO)
2024-11-15 07:30C:MDNA1.70News ReleaseMedicenna Reports Second Quarter Fiscal 2025 Financial Results and Corporate Update
2024-11-14 19:42C:MDNA1.70SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-11-14 19:42C:MDNA1.70SEDAR Interim MD & ASEDAR Interim MD & A
2024-11-11 11:31C:MDNA2.22News ReleaseMedicenna talks MDNA11 Ability-1 study results
2024-11-08 10:00C:MDNA2.47News ReleaseMedicenna Presents Preclinical Data from its Anti-PD1-IL-2 BiSKIT and IL-2 Super Agonist Programs at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)